CClinicalTrials.gg
Status unknownNCT04125407Updated Feb 10, 2020

The Effect of Sensorimotor Insoles on Gait Parameters in Adults With Flexible Flatfoot

An interventional study of Sensorimotor foot orthoses in Flexible Flatfoot, sponsored by Palacky University. Status unknown at 1 site in Czechia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-02-10.

Sponsored by Palacky University · Not applicable, Interventional, and Other

The sponsor has not verified this record recently (last verified Feb 2020), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The flatfoot is one of the most common diagnosis in foot. The main goals of its orthotic intervention in adult population are the control of the rearfoot and midfoot movement, the affection of the forefoot position and the minimalization of painful deformities. However, only low-level evidence exists proving the positive effect of orthotic insoles in these patients. The concept of sensorimotor insoles describes besides the simple mechanical correction also the targeted modulation of activity of muscles participated on the correct foot function. The aim of the project is to assess the influence of customized sensorimotor insoles on the lower limbs' kinematics and the activity of lower limbs' muscles in people with diagnosed flexible flatfoot.

The study is designed as a crossover interventional study with experimental and control group (allocation ratio 1:1). Participants' lower limbs' kinematics and muscles activity will be assessed on the baseline measurement, immediately after and 3 months after the intervention with sensorimotor insoles in the experimental group. Also, the subjective perceived effect of intervention will be assessed through the research. After a washout period, experimental and control group will swap their roles and another period of 3 months will follow. Same parameters will be assessed both at the beginning and in the end of each period.

02

Conditions studied

  • Flexible Flatfoot

Browse trials for

03

In context

Flatfoot

168 studies on the registry are indexed under Flatfoot; 41 are open to participants now.

This study's enrollment of 32 is below the median of 37 across 121 interventional studies indexed under Flatfoot.

Browse Flatfoot studies →

Lead sponsor

Palacky University is the lead sponsor of 28 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ability to stand and walk without aid or support
  • flat foot deformity confirmed by the Foot Posture Index (FPI-6) score >5 and/or the normalised navicular height truncated \<0.21

Exclusion criteria

Exclusion Criteria:

  • congenital and/or acquired neuromuscular or orthopaedic impairments that severely limit mobility and/or balance
  • any acute pain while standing and/or walking
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Investigator)
Enrollment
32 participants (actual)

Study arms

  • Experimental
    Interventional

    Experimental group will receive one customized pair of sensorimotor foot orthoses (insoles). Intervention: Other: Sensorimotor foot orthoses with any other supplementary treatment.

    Other: Sensorimotor foot orthoses

  • No intervention
    Control

    Control group will receive neither orthotic nor other supplementary intervention.

Interventions

  • OtherSensorimotor foot orthoses

    The interventional group will receive one customized pair of sensorimotor insoles and will be instructed for their using on a daily bases for the period of 3 months. The duration of using the insoles was established as 1 hour at the day after receiving the insoles. After that, the insoles' tolerance will be assessed based on the email correspondence and further adjustments of insole will be consulted with manufacturer if necessary. Recommended progression in time of using the insoles was established as +1 hour per each day (if possible) with no maximal limit. After 3 weeks, control examination will take place for the control of subjective effect of insoles. Consulting will be offered to the participants through the duration of research. Participants will not undergo any other supplementary treatment (physiotherapy, ...) focusing on the flatfoot deformity.

06

What researchers measure

Primary outcomes

  1. Foot kinematics - difference in foot eversion relative to shank during the stance phase of the gait cycle

    The two-way analysis of variance of the degree of the first peak of foot eversion measured by the optoelectronic system Vicon Vantage (Vicon Motion Systems Ltd., Oxford, Great Britain), where the factors are the "group" (intervention, control) and "time" (baseline, after 3 months).

    Time frame: 3 months

  2. Foot kinematics - difference in foot external rotation relative to shank during the stance phase of the gait cycle

    The two-way analysis of variance of the degree of the first peak of foot external rotation measured by the optoelectronic system Vicon Vantage (Vicon Motion Systems Ltd., Oxford, Great Britain), where the factors are the "group" (intervention, control) and "time" (baseline, after 3 months).

    Time frame: 3 months

Secondary outcomes

  1. Surface electromyography - difference in muscle activity by parameter "mean" during the stance phase of the gait cycle

    The two-way analysis of variance of the mean activity of the tibialis anterior, peroneus longus and gastrocnemius medialis muscles measured by the TrignoTM Wireless Systems (Delsys Inc., Natick, MA, USA) and normalised to their peak activity during the stance phase of the gait cycle, where the factors are the "group" (intervention, control) and "time" (baseline, after 3 months).

    Time frame: 3 months

Other outcomes

  1. Global Rating of Change Scale

    Subjective evaluation of overall change in health status on the 11-point scale after 3 month from the baseline, where 0 means "unchanged", -5 means "very much worse" and +5 means "completely recovered".

    Time frame: 3 months

07

Study locations

1 site
  • Faculty of Physical Culture, Palacky University Olomouc
    Olomouc, 77111, Czechia
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 10, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04125407
Lead sponsor
Palacky University
Responsible party
Zdenek Svoboda (Assistant Professor, Palacky University) — Principal investigator
First posted
Oct 14, 2019
Start date
Oct 22, 2019
Primary completion
Jun 2020 (estimated)
Completion
Oct 2020 (estimated)
Last update
Feb 10, 2020

Study contacts

Ondrej Lastovicka
study director · Faculty of Physical Culture, Palacky University Olomouc

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion